Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen

被引:19
|
作者
Hsu, HY
Chang, MH
Hsieh, RP
Ni, YH
Chi, WK
机构
[1] NATL TAIWAN UNIV,COLL MED,DEPT EMERGENCY MED,TAIPEI 10764,TAIWAN
[2] NATL TAIWAN UNIV,COLL MED,DEPT PEDIAT,TAIPEI 10764,TAIWAN
[3] NATL TAIWAN UNIV,COLL MED,DEPT LAB MED,TAIPEI 10764,TAIWAN
[4] DEV CTR BIOTECHNOL,TAIPEI,TAIWAN
关键词
D O I
10.1002/hep.510240607
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The immune responses to hepatitis B vaccine were studied in 11 hepatitis B surface antigen (HBsAg) carrier children who had cleared HBsAg but failed to develop hepatitis B surface antigen antibodies (anti-HBs) in sera (group 1), 5 HBsAg carrier children who had cleared HBsAg and developed detectable anti-HBs in sera (group 2), and 5 healthy subjects seronegative for all hepatitis B virus (HBV) markers (group 3), After receiving three doses of HB vaccine, group 1 subjects failed to develop detectable anti-HBs, Subsequently, each subject of the three groups was given one dose of the same vaccine for a cellular immunity study, and a measurable proliferation of peripheral blood mononuclear cells (PBMC) to HBsAg was detected in 1 of 8 (12.5%), 0 of 5, and 4 of 5 (80%) of the cases in each group, respectively, after vaccination, The removal of CD8(+) cells enhanced the HBsAg blastogenic response in group 3 but did not reverse the unresponsiveness in group 1 and group 2 subjects, The addition of interleukin (IL)-2 in culture reversed unresponsiveness in all cases except one case in group 1, Compared with before vaccination, PBMC from group 2 subjects produced significantly less interferon gamma (IFN-gamma) and more IL-4 in response to HBsAg after vaccination, a cytokine response not observed in group 1 subjects, HLA typing indicated that 3 of 10 patients in group 1 (30%) and 1 of 5 patients in group 2 (20%) had HLA-DRw14-DRw52, a marker previously linked to low anti-HBs response to hepatitis B vaccine in Taiwan, We conclude that the underlying causes of poor anti-HBs response in group 1 subjects are multifactorial, including specific failure of antigen presentation or T-cell activation, or the lack of T helper (Th)2 cell-like response to HBsAg, HLA-DRw14-DRw52 does not confer absolute nonresponsiveness to HBsAg, These patients are not benefited by hepatitis B immunization.
引用
收藏
页码:1355 / 1360
页数:6
相关论文
共 50 条
  • [21] Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B
    Togo, S.
    Arai, M.
    Tawada, A.
    Chiba, T.
    Kanda, T.
    Fujiwara, K.
    Imazeki, F.
    Yokosuka, O.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (10) : E508 - E515
  • [22] Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
    Janssen, Harry L. A.
    Sonneveld, Milan J.
    Brunetto, Maurizia R.
    GUT, 2012, 61 (05) : 641 - 645
  • [23] Hepatitis B Vaccination Coverage and Prevalence of Hepatitis B Surface Antigen among Children in French Polynesia, 2014
    Patel, Minal K.
    Le Calvez, Evelyne
    Wannemuehler, Kathleen
    Segalin, Jean-Marc
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 94 (06): : 1370 - 1375
  • [24] Comparison of two immunoassays for quantification of hepatitis B surface antigen in Chinese patients with concomitant hepatitis B surface antigen and hepatitis B surface antibodies
    Weiwei Liu
    Yao Hu
    Yannan Yang
    Tingting Hu
    Xinyu Wang
    Archives of Virology, 2015, 160 : 191 - 198
  • [25] HEPATITIS-B INFECTION AND HEPATITIS-B SURFACE-ANTIGEN CARRIER STATE
    TAYLOR, PE
    ONEILL, E
    MACKELL, K
    KELEN, AE
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1976, 67 (02): : 133 - 133
  • [26] Comparison of two immunoassays for quantification of hepatitis B surface antigen in Chinese patients with concomitant hepatitis B surface antigen and hepatitis B surface antibodies
    Liu, Weiwei
    Hu, Yao
    Yang, Yannan
    Hu, Tingting
    Wang, Xinyu
    ARCHIVES OF VIROLOGY, 2015, 160 (01) : 191 - 198
  • [27] Effects of hepatitis B vaccination on hepatitis B surface antigen in neonates and its change in vivo
    Wang, Shuqi
    Bai, Yuting
    Yuan, Fangyuan
    Wang, Ting
    Luo, Wenyi
    Luo, Can
    Wang, Qiang
    Wang, Dongsheng
    ASIAN BIOMEDICINE, 2022, 16 (05) : 265 - 272
  • [28] ANTIBODY TO HEPATITIS-B SURFACE ANTIGEN IN IMMUNE SERUM GLOBULIN
    HOOFNAGLE, JH
    GERETY, RJ
    BARKER, LF
    TRANSFUSION, 1975, 15 (05) : 408 - 413
  • [29] Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B
    Fung, James
    Lai, Ching-Lung
    Yuen, Man-Fung
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (06) : 717 - 726
  • [30] Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues
    Chen, Lizhang
    Liu, Fuqiang
    Fan, Xuegong
    Gao, Jianming
    Chen, Nengzhi
    Wong, Tom
    Wu, Jun
    Wen, Shi Wu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (01) : 20 - 23